Kent business park to home medical cannabis factory

Jazz Pharmaceuticals are to build a new factory at Kent Science Park having secured a $100million investment.

One hundred high skill jobs are expected to be created by the new venture - the construction of a new medical cannabis factory.

The investment was made by Jazz Pharmaceuticals and is the largest capital investment they have ever made.

Jazz secured GW following a $7.2bn takeover.

The company believe the move will boost their revenues from $3bn to $5bn by 2025.

Science minister George Freeman said the investment was a “big sign of confidence in the UK life science ecosystem”, which the country has been looking to strengthen post-Brexit.

GW commercially grows cannabis at secret locations across the country.

The company has been developing cannabis-based medicines for over two decades and is pursuing regulatory approval for its medicines. 

Its first medicine, Sativex, was approved in 2005 with its second, Epidiolex, approved in the U.S. in 2018.

Read more - Isotropic Systems’ terminal completes trials across all orbits